Full list of 216 NHS medicines in short supply – as more ADHD and heart drugs face issues, tell me about this news in (https://www.thesun.co.uk/health/40513624/nhs-medicine-shortage-hits-adhd-heart-drugs/)

The report details a significant escalation in prescription drug shortages across the NHS in the UK, highlighting that 216 medicines have been recorded in short supply or facing severe supply chain disruptions.

1. Most Severely Affected Treatments

• ADHD Medications: Persistent global manufacturing bottlenecks and soaring demand have hit key Attention Deficit Hyperactivity Disorder treatments, particularly stimulant drugs such as methylphenidate (e.g., Concerta, Equasym, Medikinet) and lisdexamfetamine (Elvanse), leaving many patients rationing doses or searching multiple pharmacies.

• Cardiovascular & Heart Drugs: Essential medications for heart conditions, including certain beta-blockers, blood pressure regulators, cholesterol-lowering statins, and antiarrhythmics, are facing critical stock gaps, forcing clinicians to search for bioequivalent or alternative formulations.

• Other Vital Categories: The wider shortfall extends to common generic medicines, hormone replacement therapy (HRT), antibiotics, diabetes treatments (such as GLP-1 receptor agonists), and epilepsy drugs.

2. Primary Causes of the Shortages

• Global Supply Chain & Manufacturing Delays: Pharmaceutical companies cite factory capacity constraints, delays in active pharmaceutical ingredients (APIs), and quality assurance pauses.

• Sharp Demand Increases: Post-pandemic surges in diagnosis and prescription rates (especially for ADHD and metabolic conditions) have outpaced production quotas.

• UK-Specific Market & Pricing Pressures: Trade representativesincluding the British Generic Manufacturers Association (BGMA)have noted that strict pricing caps, high statutory rebates, and increased trade/regulatory friction post-Brexit make the UK market less commercially resilient and more prone to supply redirection compared to other territories.

3. Patient Impact and NHS Measures

• Pharmacy Pressures: Community pharmacists report spending unprecedented hours daily contacting wholesalers and prescribers to obtain alternatives or issue Serious Shortage Protocols (SSPs).

• Clinical Guidance: Patients facing missing prescriptions are advised not to abruptly stop medications without medical oversight, and instead consult their GP or specialist to discuss temporary dose adjustments, branded alternatives, or clinical substitutions.